Vivek Ahuja to present ArisGlobal Lunch-and-Learn session at DIA Pharmacovigilance and Risk Management Conference
Miami, Florida, 15th January, 2018 – ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, announced that Vivek Ahuja, Vice President, Global Pharmacovigilance at ArisGlobal, will present a session at the January 22nd closed-door “Lunch and Learn” series, held at the DIA Pharmacovigilance and Risk Management Conference, scheduled for January 23-25, 2018 in Washington, D.C. “How Automation Can Deliver the Holy Grail in Safety,” will share how cognitive computing technologies can automate a multitude of tasks in pharmacovigilance (PV) to achieve significant benefits:
- Increased productivity
- Reduced adverse event case processing time
- Reduced overall expense
- Improved compliance
Held January 22, 12:30-2:00 p.m., invited attendees will learn about the scope of automation in PV and the application of cognitive computing technologies in case processing to achieve greater information transparency and more rigorous patient safety management. Attendees will leave with a better understanding of the expected productivity gains and improvements in case processing to be achieved.
“Marketing Authorization Holders continue to face challenges in managing the ever increasing cost of meeting the stringent pharmacovigilance regulatory obligations,” said Vivek. “This lunch-and-learn will detail how organizations can counter these challenges and become more sophisticated and achieve compliance more efficiently as compared to traditional PV systems.”
Vivek utilizes his extensive experience in product development and patient safety by supporting innovations to accelerate great ideas and taking lifesaving solutions to scale. Served in leadership roles with global/regional responsibilities for the past ten of his seventeen years of work experience in complex multi-country, cross cultural environments, he is keen to share his experience in the field of drug safety and its interface with technology.
For more on this topic, read Vivek’s white paper, “Cognitive Computing in Pharmacovigilance: Revamping Drug Safety Using Advanced Computing Systems.”
ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.